Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

This trial is comparing two methods of injecting a drug called bevacizumab (which reduces abnormal blood vessel growth in the eye) in patients with a serious type of glaucoma caused by abnormal blood vessels, to see which injection method works better at lowering eye pressure. **You may be eligible if...** - You have been diagnosed with neovascular glaucoma (a serious type of glaucoma caused by abnormal blood vessels in the eye) - Your eye pressure is higher than 21 mmHg and you need a surgical procedure (trabeculectomy) - You are at least 18 years old - You have some remaining vision (at least able to detect hand movement) - You have abnormal blood vessels visible on the iris or in the eye's drainage angle - You are willing to participate and sign the consent form **You may NOT be eligible if...** - You have already had certain eye surgeries or treatments that would affect the results - You are unable to return for follow-up visits - You have other eye conditions that would interfere with the study Talk to your doctor to see if this trial is right for you.